Fernando Bergasa-Caceres

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Molecular Dynamics Simulations

Single Molecule

Top Venues

The journal of physical chemistry. B

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Fernando Bergasa-Caceres, Herschel A Rabitz
A Perspective on Interdicting in Protein Misfolding for Therapeutic Drug Design: Modulating the Formation of Nonlocal Contacts in α-Synuclein as a Strategy against Parkinson's Disease. The journal of physical chemistry. B 128 (27) (2024)
Fernando Bergasa-Caceres, Herschel A Rabitz
A Perspective on Interdicting in Protein Misfolding for Therapeutic Drug Design: Modulating the Formation of Nonlocal Contacts in α-Synuclein as a Strategy against Parkinson's Disease. The journal of physical chemistry. B 128 (27) (2024)
Fernando Bergasa-Caceres, Herschel A Rabitz
A Perspective on Interdicting in Protein Misfolding for Therapeutic Drug Design: Modulating the Formation of Nonlocal Contacts in α-Synuclein as a Strategy against Parkinson's Disease. The journal of physical chemistry. B 128 (27) (2024)
Fernando Bergasa-Caceres, Herschel A Rabitz
A Perspective on Interdicting in Protein Misfolding for Therapeutic Drug Design: Modulating the Formation of Nonlocal Contacts in α-Synuclein as a Strategy against Parkinson's Disease. The journal of physical chemistry. B (2024)
Fernando Bergasa-Caceres, Herschel A Rabitz
A Perspective on Interdicting in Protein Misfolding for Therapeutic Drug Design: Modulating the Formation of Nonlocal Contacts in α-Synuclein as a Strategy against Parkinson's Disease. The journal of physical chemistry. B 128 (27) (2024)
Fernando Bergasa-Caceres, Herschel A Rabitz
Interdiction in the Early Folding of the p53 DNA-Binding Domain Leads to Its Amyloid-Like Misfolding. Molecules (Basel, Switzerland) 27 (15) (2022)
Fernando Bergasa-Caceres, Herschel A Rabitz
Interdiction of Protein Folding for Therapeutic Drug Development in SARS CoV-2. The journal of physical chemistry. B 124 (38) (2020)